Digital Health For Cardiovascular Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Software, Hardware, Services), By End User (Patients, Providers, Payers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 41.31 Billion
CAGR (2026-2031)	7.45%
Fastest Growing Segment	Services
Largest Market	North America
Market Size (2031)	USD 63.58 Billion

Market Overview

The Global Digital Health For Cardiovascular Market will grow from USD 41.31 Billion in 2025 to USD 63.58 Billion by 2031 at a 7.45% CAGR. Digital health for cardiovascular care encompasses mobile health applications, wearable sensors, and telehealth platforms designed to diagnose and manage heart conditions remotely. The primary drivers of this market include the increasing necessity for continuous patient monitoring and the demand for cost-efficient healthcare delivery to mitigate the rising prevalence of heart conditions. According to the American Heart Association, in 2024, approximately 48.6 percent of adults in the United States had some form of cardiovascular disease. This substantial disease burden accelerates the adoption of remote management tools intended to lower hospital readmission rates and optimize clinical outcomes.

However, the sector faces a significant challenge regarding data privacy and regulatory compliance. The strict legal frameworks governing patient data security create barriers to the seamless interoperability of devices and the sharing of sensitive health information across different platforms. These regulatory complexities can delay the commercialization of new technologies and limit their integration into standard medical practice.

Key Market Drivers

The Escalating Global Burden of Cardiovascular Diseases acts as a primary catalyst for the digital health sector, necessitating immediate structural changes in how care is delivered and financed. As heart conditions become more prevalent, healthcare systems are forced to adopt remote management tools to contain costs and prevent expensive hospitalizations. This financial imperative is underscored by the sheer scale of projected expenditures, which compels payers and providers to aggressively integrate digital platforms that enable preventive care and reduce the economic strain of acute cardiac events. According to the American Heart Association, June 2024, in the 'Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050' advisory, annual health care costs for cardiovascular conditions in the United States are projected to almost quadruple from $393 billion in 2020 to $1,490 billion by 2050.

Simultaneously, the Integration of Artificial Intelligence and Machine Learning for Predictive Diagnostics is transforming the market by enhancing the clinical utility of wearable devices. These technologies allow for the continuous analysis of biometric data, significantly improving the early detection of arrhythmias and other anomalies compared to traditional methods. According to Duke University Medical Center, September 2024, in the 'Wearable Heart Monitor Increases Diagnosis of Irregular Heart Rhythm' study, long-term continuous heart monitors identified 52% more cases of atrial fibrillation compared to usual care. This diagnostic precision is supported by a robust regulatory environment that is increasingly validating these advanced technologies for widespread clinical use. According to Cardiovascular Business, in 2025, the cardiology specialty features approximately 160 FDA-cleared clinical artificial intelligence algorithms, ranking it second among all healthcare specialties.

Download Free Sample Report

Key Market Challenges

The strict enforcement of data privacy and regulatory compliance creates a substantial impediment to the growth of the Global Digital Health For Cardiovascular Market. Manufacturers must navigate complex legal frameworks to ensure that mobile applications and wearable sensors meet rigorous standards for patient data protection. This heavy regulatory burden necessitates significant capital allocation toward compliance infrastructure rather than product innovation, effectively delaying the commercialization of new remote monitoring technologies. Consequently, smaller enterprises often struggle to enter the sector, reducing competition and slowing the overall pace of technological advancement available to cardiac patients.

Moreover, the challenge of securing interoperable devices against data breaches discourages rapid adoption by healthcare institutions. The risk of compromising sensitive health information forces organizations to implement restrictive data-sharing policies, which hinders the seamless flow of information required for effective remote management. According to the Healthcare Information and Management Systems Society, in 2025, 55 percent of healthcare organizations planned to increase cybersecurity spending to address these vulnerabilities. This diversion of financial resources toward security and compliance measures highlights the economic strain that privacy challenges impose on the sector, ultimately limiting the integration of digital tools into standard cardiovascular care.

Key Market Trends

The Advancement of Cuffless Blood Pressure Monitoring Technologies is transforming hypertension management by eliminating the physical discomfort associated with traditional inflatable cuffs. This trend integrates optical sensors into consumer-friendly wearables, enabling continuous, passive data collection for a longitudinal view of cardiovascular health. According to MobiHealthNews, July 2025, in the 'Aktiia gets FDA clearance for OTC cuffless blood pressure monitor' article, Aktiia received FDA 510(k) clearance for its G0 Blood Pressure Monitoring System, becoming the first cuffless monitor approved for over-the-counter use in the United States. This regulatory milestone signals a market shift toward passive monitoring solutions that enhance user compliance and facilitate the early detection of hypertensive events without disrupting daily activities.

Simultaneously, the Shift Toward Virtual Cardiac Rehabilitation Models is dismantling barriers such as geographic limitations and rigid scheduling that historically hampered participation in recovery programs. By leveraging mobile platforms, providers can deliver supervised exercise regimens and educational resources directly to patients' homes, significantly boosting adherence and clinical efficiency. According to the Benson-Henry Institute, September 2025, in the 'Mass General Brigham and Recora Announce Collaboration on Cardiac Program' announcement, a study demonstrated that patients enrolled in Recora's virtual program achieved a 38 percent reduction in hospital readmissions compared to those in traditional center-based rehabilitation. This trend underscores the industry's pivot toward hybrid care delivery frameworks that prioritize convenience to optimize post-acute cardiovascular outcomes.

Segmental Insights

The Services segment is projected to register the fastest growth in the global digital health for cardiovascular market, driven by the rising complexity of integrating digital platforms into existing healthcare infrastructure. Healthcare providers increasingly require professional assistance for software implementation, staff training, and ongoing system maintenance to ensure operational continuity. Additionally, stringent regulatory frameworks established by authorities such as the U.S. Food and Drug Administration necessitate continuous compliance monitoring and technical support. This sustained reliance on external expertise for lifecycle management and regulatory adherence directly accelerates the expansion of the services category.

Regional Insights

North America maintains a leading position in the global digital health for cardiovascular market, driven by the rising prevalence of chronic heart conditions and established healthcare infrastructure. The region benefits from a favorable regulatory environment, where the U.S. Food and Drug Administration frequently grants clearance for digital cardiac solutions. Additionally, reimbursement initiatives by the Centers for Medicare & Medicaid Services for remote patient monitoring significantly incentivize clinical adoption. These factors, combined with strong industry investment in connected care technologies, sustain North America’s dominance in this sector.

Recent Developments

• In August 2025, GE HealthCare unveiled a new AI-powered cardiovascular ultrasound system ahead of the European Society of Cardiology Congress in Madrid. The company announced that the platform, which had recently received both CE Mark and FDA 510(k) clearance, features automated tools designed to streamline complex imaging tasks such as Doppler measurements and left heart function assessments. By enhancing workflow efficiency and image quality, the system aims to support clinicians in the early detection and management of cardiovascular diseases. This product launch was part of the company's broader strategy to integrate digital innovations across the cardiology care pathway.
• In March 2025, Cleerly presented late-breaking clinical trial results at the American College of Cardiology's Annual Scientific Session, highlighting the capabilities of its AI-enabled quantitative computed tomography (AI-QCT) technology. The findings, drawn from the international CONFIRM2 registry, demonstrated that the company's software could identify specific coronary plaque features that significantly predict the risk of major adverse cardiovascular events, particularly in women. The research indicated that this digital approach outperformed traditional risk scores, offering a more precise method for stratifying heart disease risk in a population that has historically been underdiagnosed and undertreated.
• In November 2024, OMRON Healthcare received De Novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors equipped with AI-powered atrial fibrillation (AFib) detection. This regulatory approval marked a significant milestone, as the devices are designed to automatically analyze the pressure pulse wave during routine blood pressure checks to identify irregularities associated with AFib. The company emphasized that this machine learning capability allows for the early detection of a major stroke risk factor without requiring a separate electrocardiogram, thereby integrating critical heart monitoring into daily patient routines.
• In June 2024, a leading innovator in personal electrocardiogram (ECG) technology announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of a new handheld 12-lead ECG system. The company revealed that the device utilizes proprietary artificial intelligence technology to detect life-threatening cardiac conditions, including heart attacks, using a reduced leadset. Designed to be pocket-sized and battery-operated, the system aims to make 12-lead ECG data more accessible in various healthcare settings, such as urgent care clinics and rural facilities. The Chief Executive Officer stated that this development represents a significant advancement in disrupting traditional cardiac care pathways.

Key Market Players

• Apple Inc.
• Philips Healthcare
• Boston Scientific Corporation
• Medtronic plc
• Fitbit, Inc.
• AliveCor, Inc.
• Withings SA
• Dexcom, Inc.
• Samsung Electronics Co., Ltd.
• Huawei Technologies Co., Ltd.

By Component	By End User	By Region
Software Hardware Services	Patients Providers Payers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Digital Health For Cardiovascular Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Digital Health For Cardiovascular Market, By Component:

• Software
• Hardware
• Services

• Digital Health For Cardiovascular Market, By End User:

• Patients
• Providers
• Payers
• Others

• Digital Health For Cardiovascular Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE